Trial intelligence / Profile preview

Levetiracetam in Acute Manic Episode of Bipolar I Disorder

IRCT20211118053093N6Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of levetiracetam in bipolar I disorder, sponsored by Shiraz University of Medical Sciences. Started Aug 2023; status: completed.

02

Drugs

levetiracetam
03

Conditions

bipolar I disorder

Beyond the preview

Go deeper on IRCT20211118053093N6.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20211118053093N6.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call